http://www.zibb.com/all/theme/cq/Dendreon+Corporation Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 21 Apr 2009 11:48:48 GMTTue, 21 Apr 2009 11:48:48 GMT608831http://www.zibb.com/all/theme/cq/Dendreon+Corporation http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.bio-medicine.org/medicine-technology-1/Dendreon-Initiates-Phase-1-Clinical-Trial-of-Small-Molecule-Targeting-TRPM8-in-Cancer-4187-1/...SEATTLE April 21 /- Dendreon Corporation (Nasd... ...The Phase 1 trial will enroll three to six patients per cohort during ... ...,Dendreon,Initiates,Phase,1,Clinical,Trial,of,Small,Molecule,Targeting,TRPM8,in,Cancer,medicine,advanced medical technology,medical laboratory technology,medicalhttp://www.bio-medicine.org/medicine-technology-1/Dendreon-Initiates-Phase-1-Clinical-Trial-of-Small-Molecule-Targeting-TRPM8-in-Cancer-4187-1/Dendreon CorporationTue, 21 Apr 2009 11:48:48 GMThttp://www.forbes.com/business/2007/04/20/prostate-dendreon-stock-biz-cx_mh_0420dendreon.htmlRight now, Dendreon is the hottest stock in biotech. The tiny Seattle-based company could change the way tumors are treated with its medicine, Provenge, which teaches the immune system to battle prostate cancer.http://www.forbes.com/business/2007/04/20/prostate-dendreon-stock-biz-cx_mh_0420dendreon.htmlDendreon Corporationhttp://www.zoomedia.com/imaginationWe constantly challenge our thinking, question convention, and find the best way forward for each and every client. Clear thinking coupled with deep understanding results in powerful solutions that open up new possibilities.http://www.zoomedia.com/imaginationDendreon Corporationhttp://www.biz-lib.com/ZEB67201.htmlOver 135 reports on companies developing anti-cancer drugs from the largest blue-chip multinational to smaller specialist organisations - and all phases of development from research to launched products.http://www.biz-lib.com/ZEB67201.htmlDendreon Corporationhttp://www.crimeshieldmidlands.co.uk/aluminium_roller_shutter/aluminium_roller_shutter_136.htmlSEATTLE, Nov. 28 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that it plans to publicly offer 10,000,000 shares of its common stock pursuant to an effective registration statement previously filed with the Securities and Exchange Commission.http://www.crimeshieldmidlands.co.uk/aluminium_roller_shutter/aluminium_roller_shutter_136.htmlDendreon Corporationhttp://www.newsrx.com/article.php?articleID=3576662006 SEP 18 -- Dendreon Corporation (DNDN) announced that the company has submitted the clinical and non-clinical sections of the rolling submission of a Biologics License Application (BLA) to the U.S.http://www.newsrx.com/article.php?articleID=357666Dendreon Corporationhttp://www.drugs.com/nda/provenge_061113.htmlDrugs.com - prescription drug and over the counter medicine information available on over 24,000 approved medications and pharmaceuticals, including side effects and drug interactions.http://www.drugs.com/nda/provenge_061113.htmlDendreon Corporationhttp://www.computerbusinessreview.com/article_news.asp?guid=4FFD9A7E-769F-47C4-8157-6FC1CAF38C00Seattle-based Dendreon selected applications from Oracle's e-business suite, including Oracle Order Management, Oracle Process Manufacturing and Oracle Advanced Supply Chain Planning, to streamline logistics and manufacturing processes.http://www.computerbusinessreview.com/article_news.asp?guid=4FFD9A7E-769F-47C4-8157-6FC1CAF38C00Dendreon Corporationhttp://www.lightingdesignlab.com/locations/guth_dendreon.html(Fig 1) This cutting-edge biotech corporation requested a lighting makeover for its headquarters atrium. Goal - create a space conducive to think-tank meetings and encourage innovative thought.http://www.lightingdesignlab.com/locations/guth_dendreon.htmlDendreon Corporationhttp://www.newratings.com/headlines/Dendreon_US24823Q1076.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Dendreon_US24823Q1076.htmlDendreon Corporationhttp://www.evaluatepharma.com/CoInfo/CoInfo-DNDN.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-DNDN.htmDendreon Corporationhttp://www.investorguide.com/stock-news.cgi?ticker=DNDNTrack Any Stock Instantly Just enter up to ten of your stocks in the Stock Tracker box, click the ADD button beside any of Today's Hot Stocks, or click ADD beside any of the stocks you've Recently Viewed.http://www.investorguide.com/stock-news.cgi?ticker=DNDNDendreon Corporationhttp://www.quotelinks.com/companies/dndn.htmlStock quotes, news and charts for Dendreon Corporation Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stock earnings,http://www.quotelinks.com/companies/dndn.htmlDendreon Corporationhttp://uk.finance.yahoo.com/q?s=DNDNCopyright 2007 (c) Yahoo! UK Ltd. All rights reserved. Questions | Disclaimer | Quotes Information Quotes delayed except where indicated otherwise. Delay time is 20 mins for London stock exchange. See also delay times for other exchanges.http://uk.finance.yahoo.com/q?s=DNDNDendreon Corporationhttp://www.dyax.com/partnerships/inlicensing.html"We are impressed with the speed at which Dyax obtained high affinity and selective protease inhibitors from its antibody libraries to Dendreon's two serine protease targets.http://www.dyax.com/partnerships/inlicensing.htmlDendreon Corporationhttp://www.biospace.com/news_story.aspx?NewsEntityId=59058SEATTLE, June 6 /PRNewswire-FirstCall/ -- Dendreon Corporation today announced the pricing of its offering of $75 million aggregate principal amount of convertible senior subordinated notes due 2014.http://www.biospace.com/news_story.aspx?NewsEntityId=59058Dendreon Corporationhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=40060"CD54 cell count and CD54 upregulation are important biologically-relevant measures used to assess the potency of PROVENGE prior to patient administration," said David Urdal, Ph.D., chief scientific officer of Dendreon Corporation.http://www.pharmacychoice.com/News/article.cfm?Article_ID=40060Dendreon Corporationhttp://www.ibtimes.com/articles/20070327/dendreon-mover.htmWASHINGTON - Shares of Dendreon Corp. rose Tuesday after federal drug regulators released documents that raised questions about the company's prostate cancer vaccine that were in-line with what analysts expected.http://www.ibtimes.com/articles/20070327/dendreon-mover.htmDendreon Corporationhttp://www.fiercebiotech.com/story/dendreon-plans-to-raise-59m-to-market-provenge/2005-11-29FierceBiotech is the biotech industry daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and fda approval news.http://www.fiercebiotech.com/story/dendreon-plans-to-raise-59m-to-market-provenge/2005-11-29Dendreon Corporationhttp://www.bioexchange.com/news/news_page.cfm?id=21281The study was presented today at the 2005\r\nAmerican Society of Clinical Oncology ASCO Annual Meeting by Eric J. Small,\r\nM.D., professor of medicine and urology at the University of California, San\r\nFrancisco.Dr.http://www.bioexchange.com/news/news_page.cfm?id=21281Dendreon Corporationhttp://www.thestreet.com/print/story/10441139.htmlA version of this column was previously published to subscribers of the Biotech Select newsletter. If you're interested in subscribing, please click here for more information.http://www.thestreet.com/print/story/10441139.htmlDendreon Corporationhttp://www.nuvelo.com/RandD/rNAP/rights.htmlIn February 2004, we entered into a worldwide licensing agreement with Dendreon Corporation for upstream anticoagulant, recombinant nematode anticoagulant protein c2 (rNAPc2) and all other rNAPc proteins.http://www.nuvelo.com/RandD/rNAP/rights.htmlDendreon Corporationhttp://www.breastcancerupdate.com/bcu2005/cme/faculty.htmResearch To Practice is committed to providing its participants with high-quality, unbiased and state-of- the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities.http://www.breastcancerupdate.com/bcu2005/cme/faculty.htmDendreon Corporationhttp://www.thelabrat.com/jobs/companies/Dendreon.shtmlDendreon is a focused on the development of targeted therapies for the treatment of cancer. The Company's innovative approaches include therapeutic vaccines, monoclonal antibodies and small molecule product candidates.http://www.thelabrat.com/jobs/companies/Dendreon.shtmlDendreon Corporationhttp://www.mdlinx.com/druglinx/news-article.cfm/1853702MDLinx offers fantastic rewards to our members. Find out how you can participate and start reaping the rewards today! Earn rewards for: Referring Friends Taking Polls & Surveys Much more!http://www.mdlinx.com/druglinx/news-article.cfm/1853702Dendreon Corporation